Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by bionicjoeon Apr 30, 2019 6:35am
61 Views
Post# 29687175

RE:RE:RE:RE:RE:RE:RE:Congratulations

RE:RE:RE:RE:RE:RE:RE:CongratulationsI for one won't argue with Homestretch4me anymore. Though his facts can get a little fuzzy and self serving at times there is no denying where we sit in terms of market sentiment. I'm tired of trying to defend a management team when the best they can do is return me a $12 sp while witnessing Canopy Growth skyrocket to $70. I won't criticize them but neither will I slap them on the back for a job well done in growing my investment dollar and that's what it's all about isn't it? 

Every company gives out rosy guidance but not every company earns the support of the market in wanting to go along for the ride. At this point in the calendar year Canopy has investors lining up to board their train while Aurora can't sell a ticket. Canopy has bombarded the market with PR after PR that has enhanced it's sp while Aurora's NRs have caused nothing but red days. Short term pain for long term gain? Maybe, but until I actually start to see management turn those gains into real money for shareholders I won't make any more excuses for them.
Bullboard Posts